Vycor Medical Income Statement (2010-2023) | VYCO

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023
Revenue & cost
Revenue (Quarter) 0.07M0.07M0.11M0.15M0.14M0.23M0.45M0.43M0.27M0.22M0.29M0.23M0.23M0.32M0.31M0.33M0.31M0.36M0.48M0.31M
Cost of Revenue (Quarter) 0.01M0.01M0.02M0.02M0.04M0.04M0.08M0.08M0.04M0.03M0.03M0.03M0.03M0.04M0.03M0.03M0.04M0.03M0.04M0.03M
Gross Profit (Quarter) 0.07M0.06M0.09M0.12M0.11M0.19M0.37M0.35M0.23M0.19M0.25M0.20M0.21M0.28M0.28M0.30M0.27M0.33M0.44M0.28M
Operating items
Depreciation & Amortization - Total (Quarter) -0.04M-0.04M0.20M0.04M0.06M0.07M0.06M0.06M0.06M0.06M0.06M
Research & Development (Quarter) 762.000.00M0.01M0.02M0.04M0.03M0.02M0.02M0.05M0.03M0.02M0.03M0.02M0.01M0.01M0.01M
Selling, General & Administrative (Quarter) 0.40M0.39M0.70M0.96M1.82M1.22M0.98M1.05M0.84M0.84M0.68M0.68M0.71M0.67M0.32M0.36M0.34M0.28M0.32M0.28M
Restructuring Costs (Quarter) 0.02M
Other Operating Expenses (Quarter) 0.07M0.01M0.24M0.09M0.09M-0.15M0.12M-0.04M0.02M0.02M0.02M0.02M0.03M0.03M0.01M0.01M0.01M0.01M0.01M0.01M
Operating Expenses (Quarter) 0.48M0.41M0.94M1.03M1.91M1.31M1.17M1.11M0.97M0.96M0.78M0.80M0.82M0.76M0.33M0.37M0.36M0.30M0.35M0.30M
Operating Income (Quarter) -0.41M-0.35M-0.85M-0.91M-1.81M-1.11M-0.80M-0.76M-0.74M-0.76M-0.53M-0.60M-0.61M-0.48M-0.05M-0.07M-0.09M0.03M0.10M-0.03M
EBIT (Quarter) -0.41M-0.35M-0.85M-0.91M-1.81M-1.11M-0.80M-0.76M-0.74M-0.76M-0.53M-0.60M-0.61M-0.48M-0.05M-0.07M-0.09M0.03M0.10M-0.03M
Non-operating items
Other Non Operating Income (Quarter) 0.01M-0.01M-0.03M0.01M-0.02M0.01M0.02M-0.02M0.01M0.03M-672.0012.00-405.00-62.00-69.00-78.00
Non Operating Income (Quarter) -0.01M-0.01M0.03M-0.02M-0.03M-0.01M-0.06M-0.02M-0.02M-0.03M-0.12M-0.04M-0.05M-0.05M-0.02M-0.02M-0.02M-0.03M-0.03M-0.03M
Net income details
EBT (Quarter) -0.42M-0.36M-0.86M-0.94M-1.84M-1.15M-0.86M-0.78M-0.80M-0.79M-0.60M-0.66M-0.64M-0.52M-0.07M-0.10M-0.11M0.01M0.07M-0.05M
Tax Provisions (Quarter) 170.00
Profit After Tax (Quarter) -0.42M-0.36M-0.87M-0.94M-1.84M-1.15M-0.86M-0.78M-0.80M-0.79M-0.55M-0.66M-0.66M-0.53M-0.07M-0.10M-0.11M0.01M0.07M-0.05M
Income from Continuing Operations (Quarter) -0.42M-0.36M-0.87M-0.94M-1.84M-1.15M-0.86M-0.78M-0.80M-0.79M-0.60M-0.66M-0.64M-0.52M-0.07M-0.10M-0.11M0.01M0.07M-0.05M
Consolidated Net Income (Quarter) -0.42M-0.36M-0.87M-0.94M-1.84M-1.15M-0.86M-0.78M-0.80M-0.79M-0.60M-0.66M-0.64M-0.52M-755.00-0.00M-0.00M0.00M-707.00-0.00M-425.00
Income towards Parent Company (Quarter) -0.42M-0.36M-0.87M-0.94M-1.84M-1.15M-0.86M-0.78M-0.80M-0.79M-0.60M-0.66M-0.64M-0.52M-755.00-0.00M-0.00M0.00M-707.00-0.00M-425.00
Preferred Dividend Payments (Quarter) 0.16M0.16M0.16M0.16M
Net Income towards Common Stockholders (Quarter) -0.42M-0.36M-0.87M-0.94M-1.84M-1.15M-0.86M-0.78M-0.80M-0.79M-0.60M-0.66M-0.64M-0.52M-0.24M-0.10M-0.28M0.00M-0.16M0.07M-0.21M
Additional items
EPS (Basic) (Quarter) 0.000.000.000.000.000.00-0.92-0.14-0.14-0.14-0.10-0.11-0.10-0.08-0.010.00-0.010.000.000.00-0.01
EPS (Weighted Average and Diluted) (Quarter) 0.00-0.010.000.00-0.01
Shares Outstanding (Weighted Average) (Quarter) 4.83M726.74M753.94M770.33M5.20M5.55M5.63M5.64M5.95M6.11M6.48M30.82M31.46M32.00M31.71M32.53M32.58M32.60M
Shares Outstanding (Diluted Average) (Quarter) 31.44M32.00M32.53M37.47M32.63M
EBITDA (Quarter) -0.41M-0.35M-0.85M-0.95M-1.85M-0.91M-0.76M-0.70M-0.68M-0.70M-0.47M-0.54M-0.55M-0.51M-0.07M-0.10M-0.11M0.01M0.07M-0.05M
Interest Expenses (Quarter) 0.01M0.01M0.01M0.02M0.04M0.03M0.03M0.03M0.01M0.02M0.08M0.03M0.03M0.03M0.01M0.01M0.01M0.01M0.01M0.01M
Tax Rate (Quarter) -0.02%